Selected research
Market Structure
Global Digital Insomnia Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Digital Insomnia Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Digital Insomnia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Digital Insomnia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Digital Insomnia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Digital Insomnia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Digital Insomnia Therapeutics include Headspace Inc, Big Health, Calm, Nox Health, Pear Therapeutics, OPTT Inc, SilverCloud, Curv Health and Bodymatter Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Digital Insomnia Therapeutics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Digital Insomnia Therapeutics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Digital Insomnia Therapeutics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Digital Insomnia Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.
Digital Insomnia Therapeutics Segment by Company
Headspace Inc
Big Health
Calm
Nox Health
Pear Therapeutics
OPTT Inc
SilverCloud
Curv Health
Bodymatter Inc
PrimeNap
Digital Insomnia Therapeutics Segment by Type
Sleep Tracking App
Relaxation and Meditation Apps
CBT-I
Others
Digital Insomnia Therapeutics Segment by Application
Medical
Household
Digital Insomnia Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Insomnia Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Insomnia Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Insomnia Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Digital Insomnia Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Insomnia Therapeutics industry.
Chapter 3: Detailed analysis of Digital Insomnia Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Insomnia Therapeuticsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sleep Tracking App
- Relaxation and Meditation Apps
- CBT-I
- Others
Applications
- Medical
- Household
Companies covered
- Headspace Inc
- Big Health
- Calm
- Nox Health
- Pear Therapeutics
- OPTT Inc
- SilverCloud
- Curv Health
- Bodymatter Inc
- PrimeNap
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Digital Insomnia Therapeutics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Sleep Tracking App
- 1.2.3 Relaxation and Meditation Apps
- 1.2.4 CBT-I
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Digital Insomnia Therapeutics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Medical
- 1.3.3 Household
- 1.4 Global Market Growth Prospects
- 1.5 Global Digital Insomnia Therapeutics Growth Trends by Region
- 1.5.1 Global Digital Insomnia Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Digital Insomnia Therapeutics Market Size by Region (2021-2026)
- 1.5.3 Digital Insomnia Therapeutics Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Digital Insomnia Therapeutics Market Dynamics
- 2.1 Digital Insomnia Therapeutics Industry Trends
- 2.2 Digital Insomnia Therapeutics Industry Drivers
- 2.3 Digital Insomnia Therapeutics Industry Opportunities and Challenges
- 2.4 Digital Insomnia Therapeutics Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Digital Insomnia Therapeutics Revenue by Company (2021-2026)
- 3.2 Global Digital Insomnia Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Digital Insomnia Therapeutics Key Company Head office and Area Served
- 3.4 Global Digital Insomnia Therapeutics Company, Product Type & Application
- 3.5 Global Digital Insomnia Therapeutics Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Digital Insomnia Therapeutics Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Digital Insomnia Therapeutics Players Market Share by Revenue in 2025
- 3.6.3 2025 Digital Insomnia Therapeutics Tier 1, Tier 2, and Tier 3
4 Digital Insomnia Therapeutics Market by Type
- 4.1 Global Digital Insomnia Therapeutics Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Digital Insomnia Therapeutics Market Size by Type (2021-2032)
- 4.3 Global Digital Insomnia Therapeutics Market Size Share by Type (2021-2032)
5 Digital Insomnia Therapeutics Market by Application
- 5.1 Global Digital Insomnia Therapeutics Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Digital Insomnia Therapeutics Market Size by Application (2021-2032)
- 5.3 Global Digital Insomnia Therapeutics Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Headspace Inc
- 6.1.1 Headspace Inc Company Information
- 6.1.2 Headspace Inc Business Overview
- 6.1.3 Headspace Inc Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Headspace Inc Digital Insomnia Therapeutics Product Portfolio
- 6.1.5 Headspace Inc Recent Developments
- 6.2 Big Health
- 6.2.1 Big Health Company Information
- 6.2.2 Big Health Business Overview
- 6.2.3 Big Health Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Big Health Digital Insomnia Therapeutics Product Portfolio
- 6.2.5 Big Health Recent Developments
- 6.3 Calm
- 6.3.1 Calm Company Information
- 6.3.2 Calm Business Overview
- 6.3.3 Calm Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Calm Digital Insomnia Therapeutics Product Portfolio
- 6.3.5 Calm Recent Developments
- 6.4 Nox Health
- 6.4.1 Nox Health Company Information
- 6.4.2 Nox Health Business Overview
- 6.4.3 Nox Health Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Nox Health Digital Insomnia Therapeutics Product Portfolio
- 6.4.5 Nox Health Recent Developments
- 6.5 Pear Therapeutics
- 6.5.1 Pear Therapeutics Company Information
- 6.5.2 Pear Therapeutics Business Overview
- 6.5.3 Pear Therapeutics Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Pear Therapeutics Digital Insomnia Therapeutics Product Portfolio
- 6.5.5 Pear Therapeutics Recent Developments
- 6.6 OPTT Inc
- 6.6.1 OPTT Inc Company Information
- 6.6.2 OPTT Inc Business Overview
- 6.6.3 OPTT Inc Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 OPTT Inc Digital Insomnia Therapeutics Product Portfolio
- 6.6.5 OPTT Inc Recent Developments
- 6.7 SilverCloud
- 6.7.1 SilverCloud Company Information
- 6.7.2 SilverCloud Business Overview
- 6.7.3 SilverCloud Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 SilverCloud Digital Insomnia Therapeutics Product Portfolio
- 6.7.5 SilverCloud Recent Developments
- 6.8 Curv Health
- 6.8.1 Curv Health Company Information
- 6.8.2 Curv Health Business Overview
- 6.8.3 Curv Health Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Curv Health Digital Insomnia Therapeutics Product Portfolio
- 6.8.5 Curv Health Recent Developments
- 6.9 Bodymatter Inc
- 6.9.1 Bodymatter Inc Company Information
- 6.9.2 Bodymatter Inc Business Overview
- 6.9.3 Bodymatter Inc Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Bodymatter Inc Digital Insomnia Therapeutics Product Portfolio
- 6.9.5 Bodymatter Inc Recent Developments
- 6.10 PrimeNap
- 6.10.1 PrimeNap Company Information
- 6.10.2 PrimeNap Business Overview
- 6.10.3 PrimeNap Digital Insomnia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 PrimeNap Digital Insomnia Therapeutics Product Portfolio
- 6.10.5 PrimeNap Recent Developments
7 North America
- 7.1 North America Digital Insomnia Therapeutics Market Size (2021-2032)
- 7.2 North America Digital Insomnia Therapeutics Market Size by Type
- 7.2.1 North America Digital Insomnia Therapeutics Market Size by Type (2021-2026)
- 7.2.2 North America Digital Insomnia Therapeutics Market Size by Type (2027-2032)
- 7.2.3 North America Digital Insomnia Therapeutics Market Share by Type (2021-2032)
- 7.3 North America Digital Insomnia Therapeutics Market Size by Application
- 7.3.1 North America Digital Insomnia Therapeutics Market Size by Application (2021-2026)
- 7.3.2 North America Digital Insomnia Therapeutics Market Size by Application (2027-2032)
- 7.3.3 North America Digital Insomnia Therapeutics Market Share by Application (2021-2032)
- 7.4 North America Digital Insomnia Therapeutics Market Size by Country
- 7.4.1 North America Digital Insomnia Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Digital Insomnia Therapeutics Market Size by Country (2021-2026)
- 7.4.3 North America Digital Insomnia Therapeutics Market Size by Country (2027-2032)
- 7.4.4 North America Digital Insomnia Therapeutics Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Digital Insomnia Therapeutics Market Size (2021-2032)
- 8.2 Europe Digital Insomnia Therapeutics Market Size by Type
- 8.2.1 Europe Digital Insomnia Therapeutics Market Size by Type (2021-2026)
- 8.2.2 Europe Digital Insomnia Therapeutics Market Size by Type (2027-2032)
- 8.2.3 Europe Digital Insomnia Therapeutics Market Share by Type (2021-2032)
- 8.3 Europe Digital Insomnia Therapeutics Market Size by Application
- 8.3.1 Europe Digital Insomnia Therapeutics Market Size by Application (2021-2026)
- 8.3.2 Europe Digital Insomnia Therapeutics Market Size by Application (2027-2032)
- 8.3.3 Europe Digital Insomnia Therapeutics Market Share by Application (2021-2032)
- 8.4 Europe Digital Insomnia Therapeutics Market Size by Country
- 8.4.1 Europe Digital Insomnia Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Digital Insomnia Therapeutics Market Size by Country (2021-2026)
- 8.4.3 Europe Digital Insomnia Therapeutics Market Size by Country (2027-2032)
- 8.4.4 Europe Digital Insomnia Therapeutics Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Digital Insomnia Therapeutics Market Size (2021-2032)
- 9.2 China Digital Insomnia Therapeutics Market Size by Type
- 9.2.1 China Digital Insomnia Therapeutics Market Size by Type (2021-2026)
- 9.2.2 China Digital Insomnia Therapeutics Market Size by Type (2027-2032)
- 9.2.3 China Digital Insomnia Therapeutics Market Share by Type (2021-2032)
- 9.3 China Digital Insomnia Therapeutics Market Size by Application
- 9.3.1 China Digital Insomnia Therapeutics Market Size by Application (2021-2026)
- 9.3.2 China Digital Insomnia Therapeutics Market Size by Application (2027-2032)
- 9.3.3 China Digital Insomnia Therapeutics Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Digital Insomnia Therapeutics Market Size (2021-2032)
- 10.2 Asia Digital Insomnia Therapeutics Market Size by Type
- 10.2.1 Asia Digital Insomnia Therapeutics Market Size by Type (2021-2026)
- 10.2.2 Asia Digital Insomnia Therapeutics Market Size by Type (2027-2032)
- 10.2.3 Asia Digital Insomnia Therapeutics Market Share by Type (2021-2032)
- 10.3 Asia Digital Insomnia Therapeutics Market Size by Application
- 10.3.1 Asia Digital Insomnia Therapeutics Market Size by Application (2021-2026)
- 10.3.2 Asia Digital Insomnia Therapeutics Market Size by Application (2027-2032)
- 10.3.3 Asia Digital Insomnia Therapeutics Market Share by Application (2021-2032)
- 10.4 Asia Digital Insomnia Therapeutics Market Size by Country
- 10.4.1 Asia Digital Insomnia Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Digital Insomnia Therapeutics Market Size by Country (2021-2026)
- 10.4.3 Asia Digital Insomnia Therapeutics Market Size by Country (2027-2032)
- 10.4.4 Asia Digital Insomnia Therapeutics Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Digital Insomnia Therapeutics Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Digital Insomnia Therapeutics Market Size by Type
- 11.2.1 South America, Middle East & Africa Digital Insomnia Therapeutics Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Digital Insomnia Therapeutics Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Digital Insomnia Therapeutics Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Digital Insomnia Therapeutics Market Size by Application
- 11.3.1 South America, Middle East & Africa Digital Insomnia Therapeutics Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Digital Insomnia Therapeutics Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Digital Insomnia Therapeutics Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Digital Insomnia Therapeutics Market Size by Country
- 11.4.1 South America, Middle East & Africa Digital Insomnia Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Digital Insomnia Therapeutics Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Digital Insomnia Therapeutics Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Digital Insomnia Therapeutics Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst